July 23, 2013
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549
Attention: | Jeffrey P. Riedler, Assistant Director |
| Austin Stephenson |
| Dan Greenspan |
| Jim Peklenk |
| Mark Brunhofer |
Re: Onconova Therapeutics, Inc.
Registration Statement on Form S-1 (File No. 333-189358)
Ladies and Gentlemen:
In connection with the above-captioned Registration Statement, we wish to advise that between July 11, 2013 and the date hereof 1,170 copies of the Preliminary Prospectus dated July 11, 2013 were distributed as follows: 220 to prospective underwriters; 790 to institutional investors; 0 to prospective dealers; 160 to individuals; 0 to rating agencies and 0 to others.
We have been informed by the participating underwriters that they will comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
We hereby join in the request of the registrant that the effectiveness of the above-captioned Registration Statement, as amended, be accelerated to 4:00 p.m. Eastern Time, on Wednesday, July 24, 2013 or as soon thereafter as practicable.
[signature page follows]
Very truly yours, | ||
| ||
Citigroup Global Markets Inc. | ||
Leerink Swann LLC | ||
As representatives of the | ||
Prospective Underwriters | ||
| ||
By: | Citigroup Global Markets Inc. | |
|
| |
|
| |
By: | /s/ Brian Gleason |
|
| Name: Brian Gleason | |
| Title: Director | |
|
| |
|
| |
By: | Leerink Swann LLC | |
|
| |
|
| |
By: | /s/ Daniel Dubin |
|
| Name: Daniel Dubin | |
| Title: Vice Chairman | |
Signature Page to Acceleration Request
